Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common ED drug slow Alzheimer's? new trial aims to find out

NCT ID NCT07172815

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 29 times

Summary

This study tests whether tadalafil, a drug used for erectile dysfunction, is safe and might help people with early Alzheimer's or mild memory problems. Researchers will give 244 participants either tadalafil or a placebo daily for one year. They will check for side effects and measure changes in thinking skills and brain function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

tadalafil

What this could lead to

If it works, this could point toward a new way to slow memory loss in early Alzheimer's by improving blood flow in the brain.

What could go wrong

This is a mid-stage trial with only 244 people, so results may not apply to everyone. Tadalafil can cause side effects like headache or upset stomach, and it is not yet proven to help Alzheimer's.

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.